Z przyjemnością przedstawiamy informację o przebiegu konkursu Investment of the Year organizowanego przez Warsaw Business Journal, przy wsparciu izb bilateralnych. W konkursie inwestycje hiszpańskie reprezentowała firma ESTUDIO LAMELA. Zachęcamy wszystkie firmy czlonkowskie do uczestnictwa w przyszłych edycjach konkursu.
AstraZeneca's HUB investment wins WBJ's Investment of the Year Award
AstraZeneca Pharma Poland took home Warsaw Business Journal's Investment of the Year Award for its Research & Development Head unit (HUB), at a special celebration evening held Tuesday in Warsaw.
The research and development center is one of five run by AstraZeneca worldwide, and it is the only one in Central & Eastern Europe. The center runs clinical trials of pharmaceuticals in Poland and also coordinates such trials for AstraZeneca around the world. The investment is expected to provide 120 new jobs by the end of 2012, and will add 20 more by the end of 2013.
“We are surprised and honored,” said Patryk Mikucki, director of the HUB center, upon receiving the award. “Investments like ours show that Poles are capable of doing anything that's asked of them. We hope this award helps send that message to others.”
The celebration and award evening was held at the Amber Room restaurant in central Warsaw. Some 150 business leaders from around Poland attended, enjoying music, drinks and networking, along with the award ceremony.
The celebration marked the first time that Warsaw Business Journal has given out its Investment of the Year Award. The award and celebration evening are part of WBJ's Investing in Poland project, which also includes the annual Investing in Poland publication (the 2013 edition was launched in September) and the Investing in Poland conference, which was held this year in September at the Warsaw Stock Exchange.
“It's very important that we have taken this step to award an Investment of the Year,” said Warsaw Business Journal editor-in-chief Andrew Kureth. “We believe that this will go a long way in helping us achieve our mission of promoting Poland as a great investment location.”
Warsaw Business Journal partnered with six chambers of commerce to decide on the winner. Each chamber evaluated investments made by their member companies based on five criteria: amount of money invested, number of jobs created, innovativeness, long-term impact and sustainability. After evaluating these investments, each chamber nominated one investment for consideration.
In early November, a jury made up of business leaders met to decide upon the final winner. The members of the jury were:
• Lidia Adamska, Ph. D. – Member of the Management Board, Warsaw Stock Exchange
• Dorothy Dabrowski – Executive Director, American Chamber of Commerce
• Marcin Grodzki – Vice Director, Polish-Spanish Chamber of Commerce
• Bertrand Jannet – Vice President, French Chamber of Commerce and Industry
• Michael Kern – General Director, Polish-German Chamber of Commerce and Industry
• Paweł Kotowski – Director, Department of the Americas, Ministry of Foreign Affairs
• Agnieszka Kowalcze – Director, Scandinavian-Polish Chamber of Commerce
• Andrew Kureth – Editor-in-Chief, Warsaw Business Journal
• Sławomir Majman – President, PAIiIZ
• Jacek Socha – Advisory Department and the Deputy Chairman of PwC in Poland
• Joe Tunney – President, British Polish Chamber of Commerce
Each of the nominated investments were profiled in WBJ over several weeks in October and November. Along with AstraZeneca's HUB investment, the other nominated investments were:
Estudio Lamela's design of the Lublin City Stadium
(nominated by the Spanish-Polish Chamber of Commerce)
Profile here [http://www.wbj.pl/article-60863-lublin-city-stadium-has-regeneration-in-mind.html]
Itella's Financial Shared Service Centre & IT Competence Centre in Toruń
(nominated by the Scandinavian-Polish Chamber of Commerce)
Profile here [http://www.wbj.pl/article-60865-itella-touts-torun-centers-sustainability-innovativeness.html]
Pittsburgh Glass Works' windshield production facility in Środa Śląska
(nominated by the American Chamber of Commerce in Poland)
Profile here [http://www.wbj.pl/article-60861-pittsburgh-glass-works-facility-eyes-innovation-energy-reduction.html]
Servier's manufacturing plant and International Clinical Trial Centre in Warsaw
(nominated by the French Chamber of Commerce and Industry in Poland)
Profile here [http://www.wbj.pl/article-60862-servier-focuses-on-rd-education.html]
The AstraZeneca investment was nominated by the British Polish Chamber of Commerce
Profile here [http://www.wbj.pl/article-60899-astrazeneca-invests-in-polish-rd-center.html]
“We had five really great nominations,” said Mr Kureth. “I want to emphasize what a difficult choice the jury had in making its selection, because we really loved all of these projects, and we know that each of them is going to make a positive impact on the Polish market.”
Warsaw Business Journal would like to thank its Investing in Poland project partners:
- PAIiIZ
- PwC
- American Chamber of Commerce
- British Polish Chamber of Commerce
- French Chamber of Commerce and Industry
- Polish-German Chamber of Commerce and Industry
- Polish Spanish Chamber of Commerce
- Scandinavian-Polish Chamber of Commerce
- Warsaw Stock Exchange
- Military Property Agency
- Łódź Special Economic Zone
- Lublin City
- Szczecin City
- Bilans Tax Office
- Qualia Development
- Amber Room Restaurant
Here's the video we showed explaining why we decided to create this award as part of our Investing in Poland project: http://www.youtube.com/watch?v=A-uaJ0p5Pyc&feature=youtu.be.